Shandong Weigao Group Medical Polymer revises and adopts board diversity policy; adoption date set for March 27, 2026

Reuters03-27
<a href="https://laohu8.com/S/SHWGF">Shandong Weigao</a> Group Medical Polymer revises and adopts board diversity policy; adoption date set for March 27, 2026
  • Weigao Medical Polymer revised and adopted a Board Diversity Policy on March 27, 2026.
  • The policy states that board appointments will be based on merit while taking diversity, including gender diversity, into account.
  • Nomination Committee reviews of board structure, size, and composition are to be conducted at least annually, considering factors such as skills, experience, independence, age, and gender.
  • The company said it will ensure the board is not composed of a single gender.
  • Progress against any measurable diversity objectives, if set, is to be disclosed annually in the corporate governance report in the annual report.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12073397), on March 27, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment